Source - SMW
Ergomed has appointed Dr Dan Weng as its new chief executive and a board director from 1 July.

He will takeover the role from founder Dr Miroslav Reljanovic who will become executive vice-chairman.

Weng will join Ergomed  from EPS Holdings, a global CRO listed on the Tokyo Stock Exchange.

Ergomed said Reljanovic would support Weng and the board in growing and developing the group's CRO offering and provide strategic guidance on Ergomed's co-development business and wholly-owned pipeline.